BioGeneration Ventures
Investor profile
Venture capital
BioGeneration Ventures has backed 9 European tech companies across 10 funding rounds between 2014 and 2026, joining rounds totalling €339M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
10
distinct rounds
Companies
9
backed
Active span
2014–2026
13 yrs
Total round €
€339M
sum of rounds joined
Deals by year
distinct rounds / yearBioGeneration Ventures — deals by year — interactive chart.
Data table
| BioGeneration Ventures — deals by year | |
|---|---|
| 2014 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Top sectors
by dealsBioGeneration Ventures — top sectors — interactive chart.
Data table
| BioGeneration Ventures — top sectors | |
|---|---|
| Healthtech | 10 |
Stages
by dealsBioGeneration Ventures — stages — interactive chart.
Data table
| BioGeneration Ventures — stages | |
|---|---|
| Series A | 3 |
| Series B | 2 |
| Early VC | 1 |
| Pre-Seed | 1 |
| Seed | 1 |
| Series C | 1 |
| Other | 1 |
Countries
by dealsBioGeneration Ventures — countries — interactive chart.
Data table
| BioGeneration Ventures — countries | |
|---|---|
| Netherlands | 5 |
| Germany | 3 |
| Belgium | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Forbion3
- Novartis Venture Fund2
- Seventure Partners2
- Thuja Capital2
- Bayern Kapital1
- BioMedPartners1
- BOM1
- Brandon Capital1
- Cambridge Innovation Capital1
- Chemelot Ventures1
- Citryll’s founders1
- Coparion1
- Curie Capital1
- EIR Ventures1
- Epidarex Capital1
- FIRST Fund1
- GIMV1
- Hadean Ventures1
- High-Tech Gründerfonds (HTGF)1
- INKEF Capital1
- Innovatiefonds Noord-Holland1
- Innovation Industries1
- Jeito Capital1
- Johnson & Johnson1
- Nordic Life Science1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Citryll | Netherlands | 2 | €104M |
| Complement Therapeutics | Germany | 1 | €72M |
| CatalYm | Germany | 1 | €50M |
| Mironid | UK | 1 | €40M |
| Confo Therapeutics | Belgium | 1 | €30M |
| Scenic Biotech | Netherlands | 1 | €28M |
| FundaMental Pharma | Germany | 1 | €10M |
| Cristal Therapeutics | Netherlands | 1 | €6.0M |
| Phosphoenix | Netherlands | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Citryll | Series B | €85M | 2024-12 |
| Complement Therapeutics | Series A | €72M | 2023-04 |
| CatalYm | Series C | €50M | 2022-11 |
| Confo Therapeutics | Series A | €30M | 2019-04 |
| Scenic Biotech | Series A | €28M | 2022-03 |
| Citryll | Other | €19M | 2020-02 |
| FundaMental Pharma | Seed | €10M | 2022-11 |
| Cristal Therapeutics | Early VC | €6.0M | 2014-12 |